Fulcrum Therapeutics FULC Q1 2026 Earnings NarrowerthanExpected Loss Despite Mild Stock Dip STRR Q1 2026 Earnings Significant EPS Miss But Stock Gains 342 VNO Q1 2026 Earnings EPS Misses as Office Headwinds Persist RPT Q1 2026 Earnings Significant EPS Miss Stock Declines SherwinWilliams SHW Q1 2026 Earnings EPS Beat Amidst Steady Demand and Cost Discipline Medalist Diversified Inc MDRR Q2 2021 Earnings Earnings Beat Despite Negative EPS Stock Declines on Revenue Uncertainty